Depression - Metabolism
Research News and Information

Saturday, November 21, 2009

Polyunsaturated fatty acid status in attention deficit hyperactivity disorder, depression, and Alzheimer's disease: towards an omega-3 index for mental health?

29 Sep 2009 Interest in the role of polyunsaturated fatty acids (PUFAs), particularly long-chain (LC) omega-3 (n-3) PUFAs, in mental health is increasing. This review investigates whether n-3 PUFA levels are abnormal in people with three prevalent mental health ... Read more...

Trilostane exerts antidepressive effects among wild-type, but not estrogen receptor [beta] knockout mice.

3 Aug 2009 Women with estrogen receptor (ER) positive breast cancer, who are treated with the ER blocker, tamoxifen, have an increased risk of depression. Trilostane, a 3b-hydroxysteroid dehydrogenase inhibitor, is now being used to treat tamoxifen-insensitive ... Read more...

Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus.

30 Jul 2009 CONTEXT: Neural substrates for low cognitive performance and depression, common long-term central nervous system-related changes in patients with type 1 diabetes mellitus, have not yet been studied. OBJECTIVE: To investigate whether prefrontal ... Read more...

Latest indexed articles for 'Depression - Metabolism'

These are the very latest articles for this heading:

• Polyunsaturated fatty acid status in attention deficit hyperactivity disorder, depression, and Alzheimer's disease: towards an omega-3 index for mental health? 29 Sep 2009
• Trilostane exerts antidepressive effects among wild-type, but not estrogen receptor [beta] knockout mice. 3 Aug 2009
• Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus. 30 Jul 2009
• Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease. 30 Jul 2009
• Corticotropin-releasing factor, serotonin, and sex: keys to the castle of depressive illness. 30 Jul 2009
• Altered brain serotonin transporter and associated glucose metabolism in Alzheimer disease. 15 Jul 2009
• Antidepressant treatment facilitates dopamine release and drug seeking behavior in a genetic animal model of depression. 13 Jul 2009
• Amygdala hyperactivation in untreated depressed individuals. 26 Jun 2009
• The Flinders Sensitive Line of rats, a rat model of depression, has elevated brain glucose utilization when compared to normal rats and the Flinders Resistant Line of rats. 24 Jun 2009
• Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity. 22 Jun 2009
• Chronic immobilization stress induces anxiety- and depression-like behaviors and decreases transthyretin in the mouse cortex. 15 Jun 2009
• [Influence of electroacupuncture on hippocampal somatostatin (SS) and SS mRNA expression in chronic stress-induced depression rats] 30 May 2009
• [Serotonin and suicide] 30 May 2009
• Quality of life, depression, and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy. 30 May 2009
• Positive correlation between the density of neuropeptide y positive neurons in the amygdala and parameters of self-reported anxiety and depression in mesiotemporal lobe epilepsy patients. 29 May 2009
• Sex differences in oxidant/antioxidant balance under a chronic mild stress regime. 25 May 2009
• Behavior in the forced swim test and neurochemical changes in the hippocampus in young rats after 2-week zinc deprivation. 18 May 2009
• AGN-2979, an inhibitor of tryptophan hydroxylase activation, does not affect serotonin synthesis in Flinders Sensitive Line rats, a rat model of depression, but produces a significant effect in Flinders Resistant Line rats. 18 May 2009
• Peripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamic-pituitary-adrenal axis regulation. 16 May 2009
• Depression-like behavior in the forced swimming test in PACAP-deficient mice: amelioration by the atypical antipsychotic risperidone. 13 May 2009

See a longer list of these articles.

Technical information about 'Depression'

Definition: Depressive states usually of moderate intensity in contrast with major depression present in neurotic and psychotic disorders.

Descriptor UI: D003863

Alternative terms: Depression; Depressions; Depressive Symptoms; Depressive Symptom; Symptom, Depressive; Symptoms, Depressive; Emotional Depression; Depression, Emotional; Depressions, Emotional; Emotional Depressions;

Related Mesh Headings: Antidepressive Agents;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; diagnosis; diet therapy; drug therapy; economics; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; rehabilitation; surgery; therapy; urine; ultrasonography; virology;

Tree Number: F01.145.126.350;

Technical Notes: human & animal; /drug ther: consider also ANTIDEPRESSIVE AGENTS; do not confuse this or X ref (depression of "moderate intensity") with DEPRESSIVE DISORDER ("prominent & relatively persistent" depression): psychiatrists differentiate on basis of degree